AdAlta Ltd.
AdAlta Ltd. (ASX: 1AD) is a biotechnology company based in Australia, specializing in the development of innovative therapeutic solutions for various diseases. The company focuses on the discovery and development of monoclonal antibodies, utilizing its proprietary i-body platform technology to create a new class of biologics with potential applications in oncology and other therapeutic areas. AdAlta aims to address significant unmet medical needs through its advanced research and development efforts.